Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Supracal is a multi-ingredient nutritional supplement developed by Pharmed. It is primarily formulated to support bone and joint health, manage calcium and vitamin D deficiencies, and prevent conditions such as osteoporosis, osteopenia, osteomalacia, and rickets. The standard formulation of Supracal contains calcium citrate (a highly bioavailable and stomach-friendly form of calcium), vitamin D3 (cholecalciferol) to enhance calcium absorption, magnesium to assist in calcium utilization and muscle function, and zinc to support bone mineralization and immune health. It is widely used as a preventive and therapeutic supplement, particularly during pregnancy, lactation, and in postmenopausal women or elderly individuals at risk of bone loss.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Supracal (Pharmed Limited).